DEA doing the lords™ work
DEA is proposing new rules updating the Ryan Haight Act, which will make life harder for TRT patients. The proposal is directed at schedule III, IV, and V non narcotic medications prescribed through telemedicine. Testosterone is considered a Schedule III medication.
it would require in person evaluations and prescriptions of no more than 30 day supply. All this will do is increase costs in both $$ and time, and could potentially leave lots of ppl without access to TRT.
comment on the ruling here to try and stop this nonsense.
Federal Register
::
Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation